- Home
- PLSE vs CINT Comparison
PLSE vs CINT Comparison
Compare PLSE & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | CINT |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 566.6M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLSE | CINT |
|---|---|---|
| Price | $15.01 | $4.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $22.00 | $6.96 |
| AVG Volume (30 Days) | ★ 183.4K | 122.7K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.10 |
| EPS | N/A | ★ 0.27 |
| Revenue | $86,000.00 | ★ $467,906,000.00 |
| Revenue This Year | N/A | $13.17 |
| Revenue Next Year | $1,002.94 | $13.24 |
| P/E Ratio | ★ N/A | $16.21 |
| Revenue Growth | N/A | ★ 1.90 |
| 52 Week Low | $12.56 | $3.98 |
| 52 Week High | $25.00 | $8.00 |
Technical Indicators
Market Signals| Indicator | PLSE | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 55.35 | 40.85 |
| Support Level | $14.33 | $4.44 |
| Resistance Level | $15.96 | $4.91 |
| Average True Range (ATR) | 0.73 | 0.15 |
| MACD | 0.23 | -0.02 |
| Stochastic Oscillator | 61.27 | 0.00 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About CINT CI&T Inc
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.